Sunitha Lakshminarayanan

Sunitha Lakshminarayanan

Directeur Technique/Scientifique/R&D chez MELINTA THERAPEUTICS, INC.
Health Technology
Consumer Services

Profil

Sunitha Lakshminarayanan is Chief Technology Officer at Melinta Therapeutics, Inc. since 2024.
Former roles include Senior Vice President & Head-Product Development at Actinium Pharmaceuticals, Inc. from 2022 to 2024, and Executive Director-Cell Therapy Engineering at Bristol Myers Squibb Co. Education includes an MBA from Northwestern University, graduate studies at The Pennsylvania State University, and undergraduate studies at Coimbatore Institute of Technology.

Postes actifs de Sunitha Lakshminarayanan

SociétésPosteDébut
MELINTA THERAPEUTICS, INC. Directeur Technique/Scientifique/R&D 01/09/2024

Anciens postes connus de Sunitha Lakshminarayanan

SociétésPosteFin
ACTINIUM PHARMACEUTICALS, INC. Corporate Officer/Principal 01/09/2024
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal -
Voir l'expérience en détail de Sunitha Lakshminarayanan

Formation de Sunitha Lakshminarayanan

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

18

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Sunitha Lakshminarayanan